The MHRA has approved sebetralstat (Ekterly) as the first oral, on-demand treatment for hereditary angioedema (HAE) attacks ...

Vertex Pharmaceuticals has announced a broad reimbursement agreement with NHS England for ALYFTREK ...

Pierre Fabre Laboratories have received marketing authorisation in China for BRAFTOVI (encorafenib) in combination with ...

Researchers at Imperial College London have discovered that an unusual DNA structure could be key to reversing chemotherapy ...

Actithera has secured $75.5 million in an oversubscribed Series A round to support the clinical development of its lead ...

BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...

The Government is set to amend UK medical devices regulations by adopting EU Common Specifications for high-risk in vitro ...

Osivax has released phase 2a trial data confirming that its broad-spectrum flu vaccine candidate, OVX836, can be safely ...

This year’s NHS ConfedExpo took place on 11 to 12 June at Manchester Central, bringing together around 9,000 attendees. Among them were over 5,000 health and care leaders, with roughly one in three ...